Summary Nuclear polyploidization in the livers of CF-I mice, exposed to dieldrin (0, 1, 5 and lOppm in the diet), was studied up to the median time of liver tumour development (ranging from 15 to 27 months) in the respective treatment groups. In untreated controls nuclear polyploidization is characterized by a linear increase of octaploid nuclei with age. Approximately 4 months before tumour development a reduction in the tetraploid to diploid ratio is observed. Dieldrin treatment was found to enhance nuclear polyploidization in the initial phases of treatment, as expressed by a dose-dependent increase in octaploid nuclei. In 'steady-state' situations all age dependent changes in the level of polyploidization found in controls were also found in dieldrin treated mice. However, these changes occurred at an increasingly earlier age with higher dieldrin treatment levels. The decrease in the tetraploid:diploid ratio always takes place a few months before tumour development. This change in the ploidy level may thus be related to the subsequent liver tumour formation. The liver tumours themselves appear to originate from a diploid stem line, and were found to increase their degree of polyploidization during growth, eventually developing aneuploid nuclei. A comparison of nuclear polyploidization and liver tumour formation in CF-1 mouse liver for the given dietary dieldrin concentrations showed that liver tumour formation was associated with a constant level of polyploidization. Since polyploidization is an age-dependent process, these findings suggest that liver tumour formation is imminent at a constant biological age and that dieldrin may advance the biological age of CF-I mouse liver.The CF-l mouse strain is characterized by the development of 'spontaneous' liver tumours when they reach an advanced age. Continuous treatment with microsomal enzyme inducers, such as drugs, food additives and pesticides, results in an induction of liver microsomal enzyme systems, liver enlargement and an in increase in total liver DNA in the initial phases of treatment (Wright et al., 1972(Wright et al., ,1977Tennekes et al., 1981). Thereafter a 'steady-state' situation is maintained, in which the aforementioned remain on a plateau level (i.e., no further increases or decreases of the parameters occur). The induced changes are reversible upon withdrawal and elimination of the compound and are not accompanied by evidence of liver damage. Thus, these changes are likely to be an adaptation of the liver to increased functional demands. However, exposure to microsomal enzyme inducers, such as dieldrin has been shown to enhance liver tumour formation in these mice (Walker et al., 1973; Tennekes et al., 1985).Microsomal enzyme inducers are also known to enhance nuclear polyploidization in rodent liver (Bohm & Noltemeyer, 1981). In a recent study (van Ravenzwaay et al., 1987) it was reported that nuclear polyploidization in livers of CF-I mice increased proportionally to the dietary dieldrin concentration within a few weeks after the initiati...